Non-Helium Magnetoencephalography for Identifying Neurobiological Features and Functional Biomarkers in Children With Autism Spectrum Disorder: An Observational Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this observational study is to learn how brain activity in children with autism spectrum disorder (ASD) differs from typical developing children using magnetoencephalography (MEG). The main questions this study aims to answer are: Do children with ASD show different patterns of neural oscillation compared to typically developing children? Can MEG identify specific brain features that help ASD diagnosis? Participants will undergo MEG scan in both resting and tasking state, and their brain activity will be analyzed for characteristic neural oscillations and connectivity patterns. This study may help develop better tools for early ASD diagnosis.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 6
Maximum Age: 12
Healthy Volunteers: t
View:

• Boys aged 6 to 12 years;

• Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria;

• Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test);

• Sufficient compliance to participate in MEG experiments.

Locations
Other Locations
China
Guangzhou Women and Children's medical center
RECRUITING
Guangzhou
Contact Information
Primary
Ye Song, Medical Doctor
15625984282@163.com
+86-020-81886332
Time Frame
Start Date: 2024-11-05
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 80
Treatments
ASD
Participants in the ASD group consisted of children diagnosed with Autism Spectrum Disorder according to DSM-5 criteria.
Control
Participants in the Control group consisted of typically developing children.
Related Therapeutic Areas
Sponsors
Leads: Guangzhou Women and Children's Medical Center
Collaborators: Beijing X-Magtech Technology Limited

This content was sourced from clinicaltrials.gov